vs

Side-by-side financial comparison of Alexandria Real Estate Equities (ARE) and SelectQuote, Inc. (SLQT). Click either name above to swap in a different company.

Alexandria Real Estate Equities is the larger business by last-quarter revenue ($671.0M vs $537.1M, roughly 1.2× SelectQuote, Inc.). Alexandria Real Estate Equities runs the higher net margin — 59.4% vs 12.9%, a 46.5% gap on every dollar of revenue. On growth, SelectQuote, Inc. posted the faster year-over-year revenue change (11.6% vs -11.5%). Over the past eight quarters, SelectQuote, Inc.'s revenue compounded faster (19.5% CAGR vs -6.4%).

Alexandria Real Estate Equities, Inc. (NYSE:ARE), an S&P 500® urban office real estate investment trust (REIT), is the first, longest-tenured, and pioneering owner, operator, and developer uniquely focused on collaborative life science, technology, and agtech campuses in AAA innovation cluster locations, with a total market capitalization of $31.9 billion as of December 31, 2020, and an asset base in North America of 49.7 million square feet (SF). The asset base in North America includes 31.9...

SelectQuote is a direct-to-consumer distribution platform for selling insurance policies and healthcare services. Their insurance business earns commissions by connecting consumers with insurance carriers that provide senior health, life, automobile, and home insurance. The healthcare services business mainly consists of SelectRx, an accredited pharmacy. The company went public on May 21, 2020.

ARE vs SLQT — Head-to-Head

Bigger by revenue
ARE
ARE
1.2× larger
ARE
$671.0M
$537.1M
SLQT
Growing faster (revenue YoY)
SLQT
SLQT
+23.1% gap
SLQT
11.6%
-11.5%
ARE
Higher net margin
ARE
ARE
46.5% more per $
ARE
59.4%
12.9%
SLQT
Faster 2-yr revenue CAGR
SLQT
SLQT
Annualised
SLQT
19.5%
-6.4%
ARE

Income Statement — Q1 FY2026 vs Q2 FY2026

Metric
ARE
ARE
SLQT
SLQT
Revenue
$671.0M
$537.1M
Net Profit
$398.4M
$69.3M
Gross Margin
61.8%
Operating Margin
14.0%
Net Margin
59.4%
12.9%
Revenue YoY
-11.5%
11.6%
Net Profit YoY
740.6%
30.2%
EPS (diluted)
$2.10
$0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ARE
ARE
SLQT
SLQT
Q1 26
$671.0M
Q4 25
$754.4M
$537.1M
Q3 25
$751.9M
$328.8M
Q2 25
$762.0M
$345.1M
Q1 25
$758.2M
$408.2M
Q4 24
$788.9M
$481.1M
Q3 24
$791.6M
$292.3M
Q2 24
$766.7M
$307.2M
Net Profit
ARE
ARE
SLQT
SLQT
Q1 26
$398.4M
Q4 25
$-1.1B
$69.3M
Q3 25
$-232.8M
$-30.5M
Q2 25
$-107.0M
$12.9M
Q1 25
$-8.9M
$26.0M
Q4 24
$-62.2M
$53.2M
Q3 24
$167.9M
$-44.5M
Q2 24
$46.7M
$-31.0M
Gross Margin
ARE
ARE
SLQT
SLQT
Q1 26
Q4 25
61.8%
Q3 25
41.4%
Q2 25
47.2%
Q1 25
60.2%
Q4 24
67.5%
Q3 24
55.7%
Q2 24
60.7%
Operating Margin
ARE
ARE
SLQT
SLQT
Q1 26
Q4 25
14.0%
Q3 25
-12.4%
Q2 25
-3.6%
Q1 25
5.4%
Q4 24
14.7%
Q3 24
-4.1%
Q2 24
-0.5%
Net Margin
ARE
ARE
SLQT
SLQT
Q1 26
59.4%
Q4 25
-143.3%
12.9%
Q3 25
-31.0%
-9.3%
Q2 25
-14.0%
3.7%
Q1 25
-1.2%
6.4%
Q4 24
-7.9%
11.1%
Q3 24
21.2%
-15.2%
Q2 24
6.1%
-10.1%
EPS (diluted)
ARE
ARE
SLQT
SLQT
Q1 26
$2.10
Q4 25
$-6.35
$0.26
Q3 25
$-1.38
$-0.26
Q2 25
$-0.64
$-0.06
Q1 25
$-0.07
$0.03
Q4 24
$-0.38
$0.30
Q3 24
$0.96
$-0.26
Q2 24
$0.25
$-0.17

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ARE
ARE
SLQT
SLQT
Cash + ST InvestmentsLiquidity on hand
$418.7M
$18.3M
Total DebtLower is stronger
$405.8M
Stockholders' EquityBook value
$19.4B
$359.7M
Total Assets
$34.2B
$1.4B
Debt / EquityLower = less leverage
1.13×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ARE
ARE
SLQT
SLQT
Q1 26
$418.7M
Q4 25
$549.1M
$18.3M
Q3 25
$579.5M
$10.7M
Q2 25
$520.5M
$32.4M
Q1 25
$476.4M
$80.1M
Q4 24
$552.1M
$7.3M
Q3 24
$562.6M
$10.4M
Q2 24
$561.0M
$42.7M
Total Debt
ARE
ARE
SLQT
SLQT
Q1 26
Q4 25
$12.4B
$405.8M
Q3 25
$13.6B
$393.1M
Q2 25
$13.3B
$385.1M
Q1 25
$13.1B
$391.5M
Q4 24
$12.2B
$711.9M
Q3 24
$12.7B
$680.4M
Q2 24
$12.4B
$683.3M
Stockholders' Equity
ARE
ARE
SLQT
SLQT
Q1 26
$19.4B
Q4 25
$15.5B
$359.7M
Q3 25
$16.6B
$305.1M
Q2 25
$17.2B
$351.1M
Q1 25
$17.5B
$350.2M
Q4 24
$17.9B
$326.0M
Q3 24
$18.2B
$269.4M
Q2 24
$18.3B
$316.8M
Total Assets
ARE
ARE
SLQT
SLQT
Q1 26
$34.2B
Q4 25
$34.1B
$1.4B
Q3 25
$37.4B
$1.2B
Q2 25
$37.6B
$1.2B
Q1 25
$37.6B
$1.3B
Q4 24
$37.5B
$1.3B
Q3 24
$38.5B
$1.1B
Q2 24
$37.8B
$1.2B
Debt / Equity
ARE
ARE
SLQT
SLQT
Q1 26
Q4 25
0.80×
1.13×
Q3 25
0.82×
1.29×
Q2 25
0.77×
1.10×
Q1 25
0.75×
1.12×
Q4 24
0.68×
2.18×
Q3 24
0.70×
2.53×
Q2 24
0.68×
2.16×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ARE
ARE
SLQT
SLQT
Operating Cash FlowLast quarter
$196.6M
$52.0K
Free Cash FlowOCF − Capex
$-1.0M
FCF MarginFCF / Revenue
-0.2%
Capex IntensityCapex / Revenue
76.0%
0.2%
Cash ConversionOCF / Net Profit
0.49×
0.00×
TTM Free Cash FlowTrailing 4 quarters
$8.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ARE
ARE
SLQT
SLQT
Q1 26
$196.6M
Q4 25
$312.4M
$52.0K
Q3 25
$433.5M
$-21.6M
Q2 25
$460.2M
$-37.5M
Q1 25
$207.9M
$71.1M
Q4 24
$274.2M
$-28.7M
Q3 24
$477.4M
$-16.6M
Q2 24
$411.8M
$20.0M
Free Cash Flow
ARE
ARE
SLQT
SLQT
Q1 26
Q4 25
$-1.0M
Q3 25
$-22.7M
Q2 25
$-38.0M
Q1 25
$70.2M
Q4 24
$-29.0M
Q3 24
$-17.1M
Q2 24
$19.7M
FCF Margin
ARE
ARE
SLQT
SLQT
Q1 26
Q4 25
-0.2%
Q3 25
-6.9%
Q2 25
-11.0%
Q1 25
17.2%
Q4 24
-6.0%
Q3 24
-5.8%
Q2 24
6.4%
Capex Intensity
ARE
ARE
SLQT
SLQT
Q1 26
76.0%
Q4 25
0.2%
Q3 25
0.3%
Q2 25
0.1%
Q1 25
0.2%
Q4 24
0.1%
Q3 24
0.2%
Q2 24
0.1%
Cash Conversion
ARE
ARE
SLQT
SLQT
Q1 26
0.49×
Q4 25
0.00×
Q3 25
Q2 25
-2.91×
Q1 25
2.73×
Q4 24
-0.54×
Q3 24
2.84×
Q2 24
8.82×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ARE
ARE

Same properties$431.4M64%
Tenant recoveries$178.2M27%
Non-same properties$43.3M6%
Other$18.0M3%

SLQT
SLQT

Healthcare Services Segment$230.7M43%
Pharmacy$227.2M42%
Other$30.4M6%
Final Expense$20.4M4%
Term$18.5M3%
Other Senior$6.3M1%
All Other Revenue$3.9M1%

Related Comparisons